Search research articles
Contact Us
Filters
Showing results (91-100 of 167) with videos related to
Page
of 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2015
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials
Tjalling Bosse, Elke E M Peters, Carien L Creutzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2016
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo, Tjalling Bosse, Remi A Nout, et al.
Plos One
|
March 28, 2014
Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers
Vivian M Spaans, Marjolijn D Trietsch, Stijn Crobach, et al.
Gynecologic Oncology
|
May 22, 2012
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation
Remi A Nout, Tjalling Bosse, Carien L Creutzberg, et al.
Gynecologic Oncology
|
September 25, 2020
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
Kim E Kortekaas, Esther Bastiaannet, Helena C van Doorn, et al.
Gynecologic Oncology
|
January 26, 2022
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia Leon-Castillo, Nanda Horeweg, Elke E M Peters, et al.
International Journal of Cancer
|
April 16, 2025
Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma
Vera M Witjes, Joanne A de Hullu, Dorien M A Hermkens, et al.
Cancers
|
October 2, 2020
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
Lise M van Wijk, Sylvia Vermeulen, Matty Meijers, et al.
Virchows Archiv : an International Journal of Pathology
|
May 13, 2022
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance
Pavel Dundr, Barbora Bazalová, Michaela Bártů, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 167) with videos related to
Sort By:
Page
of 17
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2015
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials
Tjalling Bosse, Elke E M Peters, Carien L Creutzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2016
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo, Tjalling Bosse, Remi A Nout, et al.
Plos One
|
March 28, 2014
Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers
Vivian M Spaans, Marjolijn D Trietsch, Stijn Crobach, et al.
Gynecologic Oncology
|
May 22, 2012
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation
Remi A Nout, Tjalling Bosse, Carien L Creutzberg, et al.
Gynecologic Oncology
|
September 25, 2020
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
Kim E Kortekaas, Esther Bastiaannet, Helena C van Doorn, et al.
Gynecologic Oncology
|
January 26, 2022
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia Leon-Castillo, Nanda Horeweg, Elke E M Peters, et al.
International Journal of Cancer
|
April 16, 2025
Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma
Vera M Witjes, Joanne A de Hullu, Dorien M A Hermkens, et al.
Cancers
|
October 2, 2020
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
Lise M van Wijk, Sylvia Vermeulen, Matty Meijers, et al.
Virchows Archiv : an International Journal of Pathology
|
May 13, 2022
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance
Pavel Dundr, Barbora Bazalová, Michaela Bártů, et al.
Page
of 17